시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 자가수혈 장치 시장 분석과 예측(-2034년) : 유형, 제품, 서비스, 기술, 용도, 최종 사용자, 프로세스, 기능, 컴포넌트
Autotransfusion Devices Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Functionality, Component
상품코드 : 1699140
리서치사 : Global Insight Services
발행일 : 2025년 04월
페이지 정보 : 영문 412 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ￦ 7,081,000
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 5,750 ￦ 8,572,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 6,750 ￦ 10,062,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.


한글목차

세계의 자가 수혈 장치 시장은 2024년 2억 9,490만 달러에서 2034년까지 4억 7,860만 달러로 확대되어 CAGR 약 5%를 보일 것으로 예측됩니다. 이 장비는 수술 관련 합병증을 줄이고 환자의 안전을 보장하는 데 필수적입니다. 이 시장을 견인하는 것은 수술 절차의 진보, 수혈 위험에 대한 의식 증가, 환자의 회복 및 건강 관리의 효율성을 촉진하는자가 혈액 수혈에 대한 선호입니다.

시장 개요:

자가 수혈 장치 시장은 주로 수술 중 혈액 보존의 필요성이 높아짐에 따라 견조한 확대를 보이고 있습니다. 압도적인 점유율을 차지하고 있어 환자 자신의 혈액을 효율적으로 채취해 재수혈하는 것으로, 동종 수혈의 필요성을 최소한으로 억제할 수 있기 때문에 선호되고 있습니다. 수술 후 자가 수혈 시스템과 같은 새로운 하위 부문이 특히 출혈량이 많은 정형외과 수술과 심장혈관 수술로 지지를 모으고 있습니다. 현 분야에서는 심혈관 질환의 이환율이 높아짐에 따라 심장 수술에 대한 수요가 증가하고 있습니다.자동화 시스템이나 실시간 모니터링 기능 등의 기술 혁신은 시장의 성장을 더욱 촉진하고 기존의 수혈법을 재구축할 것으로 기대되고 있습니다.

시장 세분화
유형 자가 수혈 시스템, 자가 수혈 액세서리
제품 온 펌프 자가 수혈 장치, 오프 펌프 자가 수혈 장치
서비스 유지보수 서비스, 교육 서비스, 컨설팅 서비스
기술 한외 여과, 원심 분리
용도 심장 수술, 정형외과, 신경 외과, 외상 사례
최종 사용자 병원, 외래수술센터(ASC), 전문 클리닉
프로세스 수술 중 자가 수혈, 수술 후 자가 수혈
기능 자동 시스템, 반자동 시스템, 수동 시스템
구성요소 펌프, 필터, 저장소, 튜브

자가 수혈 장치는 병원과 수술센터가 주된 사용자이며, 다양한 헬스케어 환경에서 큰 도입을 볼 수 있습니다. 아시아태평양은 헬스케어 투자와 의식이 높아지면서 유망한 성장 지역으로 떠오르고 있습니다. 시장 경쟁은 Medtronic, Fresenius Kabi, Haemonetics 등 기존 기업의 존재를 특징으로 하며, 이들 기업은 경쟁력을 유지하기 위해 연구개발에 지속적으로 투자하고 있습니다. 향후, 이 시장은 기술의 진보와 수술의 보급률 증가로부터 혜택을 받을 것으로 예측됩니다.

주요 동향과 촉진요인:

자가 수혈 장치 시장은 수술 증가와 환자의 안전성에 대한 관심이 높아져 성장을 이루고 있습니다. 심혈관질환 및 성형외과수술 유병률 증가가 이러한 장치에 대한 수요를 세계적으로 견인하고 있습니다. 낮은 침습 수술로의 시프트도 혈액 관리에 큰 이점을 가져오는 자가 수혈 장치의 사용 증가에 기여하고 있습니다. 혁신적인 솔루션과 전략적 파트너십에 중점을 둔 기업은 시장 점유율을 높이는 태세를 갖고 있습니다.

억제요인과 도전:

자가 수혈 장치 시장은 현재 몇 가지 심각한 억제요인과 도전을 가지고 있습니다. 주요 저해 요인은 고도의 자가 수혈 시스템에 필요한 초기 투자가 고액이기 때문에 소규모 의료시설에서는 도입하지 않을 가능성이 있습니다. 게다가, 이러한 장비의 조작 훈련을 받은 숙련된 전문가가 부족하기 때문에 지역에 따라서는 충분히 활용되고 있지 않습니다. 또한 엄격한 승인 프로세스가 제품 출시를 늦추고 신규 진출기업 시장 진입을 제한하기 때문에 규제상의 장애물도 과제가되고 있습니다. 또한 시장은 기증자 수혈과 같은 대체 혈액 관리 기술과의 경쟁에 직면하고 있습니다. 마지막으로, 지역에 따라 의료 인프라에 편차가 있기 때문에 효과적인 도입에 필요한 지원 체제가 갖추어지지 않은 시설도 있어, 자가 수혈 장치의 보급을 방해할 가능성이 있습니다. 이러한 과제는 전체적으로 자가 수혈 장치 시장의 성장과 잠재력을 방해하고 있습니다.

목차

제1장 자가 수혈 장치 시장 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 자가 수혈 장치 시장 전망

제5장 수혈 장치 시장 전략

제6장 자가 수혈 장치 시장 규모

제7장 자가 수혈 장치 시장 : 유형별

제8장 자가 수혈 장치 시장 : 제품별

제9장 자가 수혈 장치 시장 : 서비스별

제10장 자가 수혈 장치 시장 : 기술별

제11장 자가 수혈 장치 시장 : 용도별

제12장 자가 수혈 장치 시장 : 최종 사용자별

제13장 자가 수혈 장치 시장 : 프로세스별

제14장 자가 수혈 장치 시장 : 기능별

제15장 자가 수혈 장치 시장 : 컴포넌트별

제16장 자가 수혈 장치 시장 : 지역별

제17장 경쟁 구도

제18장 기업 프로파일

JHS
영문 목차

영문목차

Autotransfusion Devices Market is anticipated to expand from $294.9 million in 2024 to $478.6 million by 2034, growing at a CAGR of approximately 5%. The market encompasses medical equipment designed for blood collection and reinfusion during surgical procedures, minimizing the need for donor blood. These devices are vital in reducing transfusion-related complications and ensuring patient safety. The market is driven by advancements in surgical techniques, increasing awareness of transfusion risks, and a growing preference for autologous blood transfusion, which promotes patient recovery and healthcare efficiency.

Market Overview:

The Autotransfusion Devices Market is experiencing robust expansion, primarily driven by the growing need for blood conservation during surgical procedures. The key market segments include product type, application, and end-user. The product type segment is dominated by intraoperative autotransfusion devices, which are preferred due to their ability to efficiently collect and reinfuse a patient's own blood, minimizing the need for allogeneic blood transfusions. This dominance is attributed to advancements in device technology, improved patient outcomes, and heightened awareness of transfusion-related complications. Emerging sub-segments, such as postoperative autotransfusion systems, are gaining traction, particularly in orthopedic and cardiovascular surgeries, where blood loss is significant. These systems promise to enhance recovery rates and reduce hospital stays. The application segment is witnessing increased demand in cardiac surgeries, driven by the high incidence of cardiovascular diseases. Technological innovations, such as automated systems and real-time monitoring capabilities, are expected to further propel market growth and reshape traditional transfusion practices.

Market Segmentation
TypeAutotransfusion Systems, Autotransfusion Accessories
ProductOn-Pump Autotransfusion Devices, Off-Pump Autotransfusion Devices
ServicesMaintenance Services, Training Services, Consultation Services
TechnologyUltrafiltration, Centrifugation
ApplicationCardiac Surgery, Orthopedic Surgery, Neurological Surgery, Trauma Cases
End UserHospitals, Ambulatory Surgical Centers, Specialty Clinics
ProcessIntraoperative Autotransfusion, Postoperative Autotransfusion
FunctionalityAutomated Systems, Semi-Automated Systems, Manual Systems
ComponentPumps, Filters, Reservoirs, Tubing

Autotransfusion devices are witnessing significant adoption across various healthcare settings, with hospitals and surgical centers being the primary users. This trend is largely driven by the increasing emphasis on patient safety and the reduction of transfusion-related complications. North America remains at the forefront of this market due to advanced healthcare infrastructure, while the Asia-Pacific region is emerging as a promising area for growth, fueled by rising healthcare investments and awareness. Key players in the market are focusing on innovation and strategic partnerships to enhance their product offerings and expand their global footprint. The competitive landscape of the autotransfusion devices market is marked by the presence of established companies such as Medtronic, Fresenius Kabi, and Haemonetics, who are continually investing in research and development to maintain their competitive edge. Regulatory frameworks, particularly in North America and Europe, are pivotal in shaping market dynamics, with stringent standards ensuring product efficacy and safety. Looking ahead, the market is expected to benefit from technological advancements and the increasing prevalence of surgical procedures. However, challenges such as high costs and the need for skilled personnel may pose hurdles. Nonetheless, the integration of automated technologies and the growing demand for minimally invasive procedures are anticipated to offer substantial growth opportunities.

Geographical Overview:

The autotransfusion devices market is experiencing varied growth across different regions, each influenced by unique factors. North America leads the market, driven by advanced healthcare infrastructure and a high prevalence of cardiovascular diseases. The region's focus on reducing blood transfusion-related complications further propels market growth. In Europe, the market is expanding steadily, supported by an aging population and increased awareness of autotransfusion benefits. Stringent regulations promoting patient safety also contribute to the market's robustness. Asia Pacific presents significant growth potential, fueled by rising healthcare expenditures and technological advancements. The region's large population base and increasing surgical procedures demand efficient blood management solutions. Latin America is an emerging market with growing healthcare investments and improving medical facilities. The region's focus on enhancing surgical outcomes boosts the adoption of autotransfusion devices. The Middle East & Africa are witnessing gradual market expansion, driven by increasing healthcare awareness and government initiatives to improve healthcare access. The region's demand for cost-effective and safe blood management solutions is on the rise. Each region's distinct dynamics and healthcare priorities shape the autotransfusion devices market's trajectory, presenting lucrative opportunities for stakeholders.

Recent Development:

The autotransfusion devices market has witnessed notable developments in recent months, underscoring its evolving landscape. Firstly, Medtronic announced a strategic partnership with a leading biotechnology firm to enhance its autotransfusion systems, aiming to integrate advanced AI capabilities for improved patient outcomes. Secondly, Fresenius Kabi launched its innovative autotransfusion device, designed to offer superior efficiency and user-friendliness, setting a new standard in the market. Thirdly, the regulatory landscape saw significant changes as the US FDA introduced updated guidelines for autotransfusion devices, focusing on enhanced safety protocols and performance standards. Fourthly, a major merger was announced between two prominent players in the sector, Haemonetics and a European competitor, to expand their global footprint and leverage synergies in R&D and distribution networks. Lastly, a recent market report highlighted a robust growth trajectory for the autotransfusion devices market, driven by increasing surgical procedures and a heightened focus on patient blood management, projecting a CAGR of over 6% in the coming years.

Key Trends and Drivers:

The autotransfusion devices market is experiencing growth fueled by increased surgical procedures and a rising focus on patient safety. Key trends include technological advancements in autotransfusion systems, which enhance efficiency and reduce the need for allogeneic blood transfusions. The growing prevalence of cardiovascular diseases and orthopedic surgeries is driving demand for these devices globally. Hospitals and surgical centers are increasingly adopting autotransfusion devices to minimize transfusion-related complications and improve patient outcomes. Additionally, there is a heightened emphasis on cost-effectiveness and reducing healthcare-associated infections, which is bolstering market expansion. The shift towards minimally invasive surgeries is also contributing to the increased use of autotransfusion devices, as they offer significant benefits in blood management. Opportunities are emerging in developing regions where healthcare infrastructure is being upgraded, and awareness of the benefits of autotransfusion is rising. Companies focusing on innovative solutions and strategic partnerships are poised to capture significant market share. The market is set for continued growth, driven by technological innovations and expanding healthcare investments.

Restraints and Challenges:

The autotransfusion devices market is currently navigating several significant restraints and challenges. A primary restraint is the high initial investment required for advanced autotransfusion systems, which can deter smaller healthcare facilities from adoption. Additionally, there is a lack of skilled professionals trained in the operation of these devices, leading to underutilization in some regions. Regulatory hurdles also pose a challenge, as stringent approval processes can delay product launches and limit market entry for new players. Moreover, the market faces competition from alternative blood management techniques, such as donor blood transfusions, which are often more readily available and cost-effective. Lastly, the variability in healthcare infrastructure across different regions can impede the widespread adoption of autotransfusion devices, as some facilities may lack the necessary support systems for effective implementation. These challenges collectively hinder the growth and potential of the autotransfusion devices market.

Key Companies:

Haemonetics Corporation, Liva Nova PLC, Medtronic, Fresenius Kabi, Atrium Medical Corporation, Stryker Corporation, Terumo Corporation, Beijing Jingjing Medical Equipment, Zimmer Biomet, Advancis Surgical, Sarstedt AG and Co, Redax, Gen World Medical Devices, Global Blood Resources, Brightwake, Braile Biomedica, SB- Kawasumi Laboratories, Medela AG, Teleflex Incorporated

Sources:

World Health Organization - Global Health Observatory, U.S. Food and Drug Administration - Medical Devices, European Medicines Agency, National Institutes of Health - National Library of Medicine, Centers for Disease Control and Prevention - National Center for Health Statistics, World Bank - Health Nutrition and Population Statistics, World Federation of Hemophilia, International Society of Blood Transfusion, American Association of Blood Banks, National Blood Transfusion Council of India, International Consortium for Blood Safety, Transfusion Medicine and Hemotherapy Journal, National Health Service Blood and Transplant (UK), Australian Red Cross Lifeblood, Blood Transfusion Research Center (Iran), International Conference on Blood Transfusion Medicine, Annual Meeting of the American Society of Hematology, European Congress of Clinical Microbiology and Infectious Diseases, International Symposium on Blood Transfusion, World Congress on Transfusion Medicine.

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Autotransfusion Devices Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Autotransfusion Devices Market Outlook

5: Autotransfusion Devices Market Strategy

6: Autotransfusion Devices Market Size

7: Autotransfusion Devices Market, by Type

8: Autotransfusion Devices Market, by Product

9: Autotransfusion Devices Market, by Services

10: Autotransfusion Devices Market, by Technology

11: Autotransfusion Devices Market, by Application

12: Autotransfusion Devices Market, by End User

13: Autotransfusion Devices Market, by Process

14: Autotransfusion Devices Market, by Functionality

15: Autotransfusion Devices Market, by Component

16: Autotransfusion Devices Market, by Region

17: Competitive Landscape

18: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기